dc.creator | Smith, Jeffrey W. | |
dc.creator | Romo, Daniel | |
dc.creator | Ma, Gil | |
dc.creator | Zancanella, Manuel | |
dc.date.accessioned | 2019-06-17T17:06:45Z | |
dc.date.available | 2019-06-17T17:06:45Z | |
dc.date.issued | 2012-09-04 | |
dc.identifier.uri | https://hdl.handle.net/1969.1/177004 | |
dc.description.abstract | The present invention provides compounds having the general structure A, or a pharmaceutically acceptable derivatives thereof:
wherein R is an alkyl group, and R1 comprises at least one moiety selected from a group consisting of an alkyl, an alkenyl, an aryl, a heterocycle, hydroxyl, ester, amido, aldehyde, and a halogen. | en |
dc.language | eng | |
dc.publisher | United States. Patent and Trademark Office | |
dc.rights | Public Domain (No copyright - United States) | en |
dc.rights.uri | http://rightsstatements.org/vocab/NoC-US/1.0/ | |
dc.title | Beta-lactone compounds | en |
dc.type | Utility patent | en |
dc.format.digitalOrigin | reformatted digital | en |
dc.description.country | US | |
dc.contributor.assignee | Burnham Institute for Medical Research | |
dc.contributor.assignee | The Texas A&M University System | |
dc.identifier.patentapplicationnumber | 12/262101 | |
dc.subject.uspcprimary | 549/328 | |
dc.date.filed | 2008-10-30 | |
dc.publisher.digital | Texas A&M University. Libraries | |
dc.subject.cpcprimary | A61P 37/00 | |
dc.subject.cpcprimary | A61P 3/04 | |
dc.subject.cpcprimary | A61P 17/02 | |
dc.subject.cpcprimary | A61P 35/00 | |
dc.subject.cpcprimary | A61P 9/10 | |
dc.subject.cpcprimary | A61P 29/00 | |
dc.subject.cpcprimary | A61P 31/04 | |
dc.subject.cpcprimary | A61P 31/06 | |
dc.subject.cpcprimary | A61P 19/02 | |
dc.subject.cpcprimary | C07D 305/12 | |
dc.subject.cpcprimary | A61P 31/00 | |